In its statement, the company blamed the situation on the poor performance of 24 practices it bought in the Netherlands, and its new farm and equine divisions.
CVS says that another important factor has been employment costs, in particular the increase in market rates for locum veterinary surgeons and nurses on which it remains heavily reliant.
The company also blames its financial performance on the poor support of pharmaceutical companies, which it says it is continuing to push for transparent and 'appropriate' pricing.
Aside from trying to drive down the costs of drugs, the company says it has introduced 'additional procedures' designed to reduce the cost of employing locums, although it didn't specify what these are.
The group is also reevaluating its pipeline of acquisitions, in particular the multiples it is prepared to pay.
At the time of writing, the CVS share price had dropped over 28% to 465p overnight and 70% since the share price peaked at 1477p in November 2017.
In the game of acquisitions musical chairs, did the music just stop?
Full trading statement.
The Veterinary Medicines Directorate (VMD) has given VetSurgeon the data on which these stories were based.
In the 3.5 years since the vaccine was authorised, the incidence of suspected adverse animal reactions has been 0.064%. In other words, for every 10,000 doses sold, the VMD has received reports of 6 suspected adverse reactions. This incidence is considered 'rare', according to the following convention:
The VMD reports that amongst the 40+ authorised dog vaccines in the UK, the incidence of suspected adverse reactions ranges from 0.002% (classified 'very rare') to 0.3% (classified 'uncommon')
However, the VMD is at pains to stress that suspected adverse reaction reports should not be used to compare the relative safety of products. They are, after all, only 'suspected' adverse reactions. The reliability of suspected adverse reaction reports is further complicated by the fact that vaccination against leptospirosis rarely occurs in isolation, making it very difficult to interpret which adverse reactions are attributable to Leptospira vaccines.
Many vaccines providing protection against leptospirosis also contain components for prevention of other diseases, such as distemper, parainfluenza and parvovirus. In addition, many dogs are vaccinated concurrently against other diseases, such as kennel cough and/or rabies, and other products (e.g. flea and worm treatments) may be administered at the same visit. Therefore the clinical signs observed may be related to any of the products used or they may be unrelated.
The VMD says the majority of the most commonly reported suspected adverse reactions to Nobivac L4 are linked to allergic type reactions which are well-recognised potential side effects of any vaccine, and are presented on the product literature.
As to the newspaper claim that: "The World Small Animal Veterinary Association (WSAVA) is urging owners not to use Nobivac L4 vaccine on puppies under 12 weeks old.", the WSAVA denied this in the strongest possible terms, saying: "This statement is blatantly untrue. The WSAVA would never ‘urge owners’ and would never make recommendations about individual named commercial products."
In a statement issued in response to the newspaper story, MSD said: "Nothing is more important to MSD Animal Health than the safety and efficacy of our products, and the health and well-being of animals.
"Nobivac L4 was launched in 2013 across Europe to prevent dogs from contracting Leptospirosis which is a serious zoonotic disease. It is one of the most widely used vaccines for dogs with several million doses being used annually to successfully prevent infection in dogs."
"As a responsible animal health company, we take every adverse reaction report seriously and investigate thoroughly. Whenever possible, we work with the pet owner and attending veterinary surgeon to assemble as much clinical information as we can to help determine the cause of a pet’s health issue, and whether or not the product may have been involved .
"We report findings to governing regulatory agencies around the world (based on a country’s respective laws and policies), so that they can make a fully informed, scientific assessment about the safety of the product. We do this so that accurate safety and efficacy information is available for veterinary surgeons prescribing our products."
In a parting shot, the WSAVA said: "The WSAVA guidelines are publicly available on-line and this journalist has clearly not undertaken adequate research before publishing this article."
See: www.wsava.org/educational/vaccination-guidelines-group
Moxiclear contains moxidectin and imidacloprid.
In dogs, Moxiclear can be used for the treatment and prevention of flea infestations and as part of a treatment plan for flea allergic dermatitis. It is also indicated for lungworm, ear mites, sarcoptes mites, biting lice, round worm, hookworm, whipworm, skinworm, and prevents heartworm.
In cats, Moxiclear can be used for the treatment and prevention of flea infestation and flea allergic dermatitis, as well as ear mite infestations. It is also indicated for notoedric mange, gastrointestinal nematodes; whipworm, roundworm and hookworm, and for the prevention of heartworm disease.
In ferrets, Moxiclear can be used to treat and prevent flea infestation, and prevent heartworm.
Moxiclear is available for 4kg-40kg dogs, with four pipette fill sizes. Small cats and ferrets weighing less than 4kg are catered for with a 0.4ml pipette. Large cats weighing 4-8kg can be treated with the Moxiclear 0.8ml pipette.
Lorron Bright, Norbrook Product Manager, said: "Moxiclear offers good value, broad-spectrum parasite control for dogs, cats and ferrets. This latest launch provides our customers with an excellent value, alternative choice for a imidacloprid/moxidectin product."
Richard Palmer, Norbrook Global Head of Sales and Marketing, said: "Moxiclear spot-on is the 11th product we have launched in the past three years. Six of the new products are in the companion animal sector as we continue to strengthen our foothold in the growing global companion animal market. Norbrook is committed to delivering a strong new product pipeline, along with our multi-year £50 million investment programme."
The research, which was conducted by a team at the Royal Veterinary College led by Professor Holger Volk and Dr Benjamin Andreas Berk alongside canine behaviour and welfare scientist Dr Rowena Packer, tested the effects of an MCT oil supplement on seizure frequency in dogs with drug-resistant epilepsy.
For the double-blinded study, 28 epileptic dogs received MCT oil for three months and a placebo oil for three months.
The researchers say that overall, dogs had significantly fewer seizures during the MCT phase compared the placebo phase, and an improved owner-reported quality of life. New therapies are urgently needed to improve the quality of life of affected dogs and their owners and the results of this study offer a promising addition to other methods commonly used to treat canine epilepsy.
Dr Rowena Packer, BBSRC Research Fellow at the Royal Veterinary College, said: “Epilepsy is often a challenging and distressing condition for dog owners to manage, particularly when dogs don’t respond to anti-seizure medications in the way their owner and vet might have expected or hoped. Historically, diet has not been considered a key part of epilepsy management, but along with other recent findings, these results indicate that nutrition likely plays an important role in seizure control.
"Our novel findings indicate that a relatively small change to the diet of dogs’ with hard-to-treat epilepsy can potentially reduce the number of seizures they have, while also improving their medication side effects and overall quality of life. MCT oil offers a promising addition to the wider epilepsy management tool-kit."
Reference
Lottie, an 11-month-old Labrador puppy was found to have a very loud heart murmur during a routine check before being spayed.
An ultrasound revealed that she had several congenital defects. The two major ones were a malformation of her tricuspid valve and a very large defect of the common atrium.
Lottie was referred to the RVC’s cardiothoracic department where she underwent further ultrasound and a CT scan. The team at the RVC, which is led by Dan Brockman, Professor of Small Animal Surgery, had already performed several cutting-edge surgeries, including a world-first treatment to save the life of a dog born with a malformed tricuspid valve.
Repair of the tricuspid valve has only been performed a handful of times and has not been done at the same time as repair of a common atrium.
Lottie’s owners decided to proceed with the operation, which was undertaken at the end of July. Lottie's heart was stopped for the procedure and her circulation maintained with a heart lung machine run by perfusionist Nigel Cross from Great Ormond Street Hospital.
Poppy Bristow, Fellow in Cardiothoracic Surgery at the RVC, said: "Altogether 10 people were involved in her operation and many more for her care before and after surgery, including veterinary specialists, veterinary nurses and veterinary specialists-in-training from surgery, cardiology, anaesthesia and emergency and critical care, as well as Lottie’s referring cardiologist and her local veterinary practice.
"Lottie’s heart was stopped for an hour and a half, with the whole operation taking four hours. Her malformed tricuspid valve was released by cutting its abnormal attachments and artificial chords using Gore-Tex material were placed. Her single atrium was then divided into two using a large patch of Gore-Tex. Lottie has made a good recovery so far and was walking around and eating from the day after her surgery. She was discharged back to her owners after six days and has continued to thrive at home."
Professor Brockman added: "In Lottie, we had a young energetic dog with such a serious and life-limiting heart condition, that we were desperate to try and help her. The repair was complex but incorporated a combination of surgical manoeuvres that we had done before. With careful pre-operative planning and using our previous experience, we were able to design and execute the surgical treatment. It is still ‘early days’ but the initial signs suggest that Lottie is going to enjoy an excellent quality of life, following this operation and, we all hope, a normal lifespan."
The link emerged after six cats were taken to separate practices in England suffering with clinical signs of TB. Further tests confirmed that they were all infected with Myobacterium bovis. Seven more cats from the same household were also infected, but asymptomatic.
Researchers at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies carried out an investigation to identify the source of infection.
The one common factor identified, as detailed in their paper, was that all the animals, which were kept exclusively indoors, had been fed Natural Instinct's Wild Venison cat food.
The authors concluded that whilst not conclusive (they were not able to test the food), their research provided 'compelling, if circumstantial, evidence of an association between the commercial raw diet of these cats and their M. bovis infections.
Natural Instinct withdrew the Wild Venison product last December, as some of the ingredients were not inspected in line with EU requirements.
A spokesperson from Natural Instinct said: "Everything we do at Natural Instinct is done so with the best interests of our customers and their pets in mind. We can assure our customers that Natural Instinct followed, and continues to follow, every food standard, hygiene regulation and best practice required to produce raw pet food in the commercial marketplace.
"As a responsible manufacturer, we are regularly inspected by the Animal and Plant Health Authority (APHA). We have complied with all of the necessary requirements, and consequently APHA have confirmed they are satisfied all standards have been met by us.
"Even though we no longer manufacture and sell the Venison cat product, we are continuing to work with Food Standards Agency as part of the investigation into the Venison cat food product."
The big question is what broader implications this incident has for feeding animals with raw diets.
Professor Danièlle Gunn-Moore from the Royal (Dick) School of Veterinary Studies, a co-author of the paper, said: "With this outbreak, the problem has been feeding wild venison – the law states the stalker must have their Deer stalker level 1 qualification, but this is only a 3-day course with just one day of disease recognition etc (apparently).
"Natural Instinct apparently sourced their deer from stalkers in the Edge area re TB risk. The stalker is supposed to inspect the gralloch (innards) wild ‘on the hill’ then leave it there for wildlife to eat. They only bring the carcass in skin back with them – which means significant pathology can easily be missed.
"Do we need to strength the law? Either that, or only feed raw venison from Scotland or other areas with no M. bovis (I am ignoring all the other potential infections here).
On the broader issue of feeding cats commercial raw food, Danièlle added: "In concept I think raw food can be far more environmentally stimulating – especially for housecats.
"But that is only safe if we can master 2 things: 1) be nutritionally sound – this is now possible with good companies doing this, and 2) be free of infectious agents – and this is a real problem, especially where the meat has been minced – which they need to be to get the minerals and vitamins correctly mixed in. So I don’t see how to square the circle at present."
Conor O’Halloran et al. Tuberculosis due to Mycobacterium bovis in pet cats associated with feeding a commercial raw food diet. Journal of Feline Medicine and Surgery, 2019. DOI: 10.1177/1098612X19848455
The survey was conducted following the recent RCVS Council decision to redefine ‘Under Care’ to allow vets to prescribe remotely.
692 veterinary surgeons took part in the survey, 88.7% of which worked in practice, 8.7% worked elsewhere and 2.6% are retired.
42.4% worked in corporate practice, 42.4% at an independent practice (spooky), 9.6% locum and 2.6% at a charity.
94% worked in first opinion practice, 5.7% in referral practice.
When asked: “Do you agree with the RCVS Council decision to allow veterinary surgeons to prescribe medication without having seen / examined the animal in person?”, 78.2% said no, 13.6% said yes and 8.2% said ‘ambivalent’.
This raises an interesting discussion about the role of RCVS Council, which the College has long said is ‘representative of’, but not there 'to represent’ the profession in self-regulating.
By any measure, this decision was not ‘representative of’ the wider body of opinion.
It could be argued that electorates vote for representatives to make more informed decisions than they themselves are able, and certainly MPs have voted in ways that are not representative of the wider body of public opinion.
But this is the veterinary profession. MPs have to represent a wide cross-section of society, some groups of which might struggle to field one working brain cell between them.
By contrast, veterinary surgeons are a highly intelligent, highly educated subset of the population, who you might assume are better qualified to make decisions on matters such as these.
So why this level of disagreement? We asked respondents to select any benefits and drawbacks they think remote prescribing will bring, from a list but with the option for them to write in any we hadn’t thought of.
When asked to select benefits of remote prescribing, the majority (70.9%) selected: “Reduced cost to the pet owner (driving/parking etc)’.
39.3% said it would bring an improvement to vets’ quality of life through more flexible working.
27.5% said animal welfare would be improved through increased access to veterinary services.
14.3% said it would bring an ‘Improved client/vet relationship’.
Of those people who selected a benefit, 49.9% said the biggest benefit of remote prescribing is a reduced cost to the pet owner (driving / parking etc).
Other benefits highlighted in the comments section were
Notably, in the comments section for the benefits of remote prescribing, out of the 104 comments, 33 actually commented 'no benefit' or negatively.
When asked to select the drawbacks of remote prescribing, 94.3% selected: ‘Harm to animals caused by misdiagnoses and missed diagnoses.
68% said: Worsened client / vet relationship
60.6% said: Threat to independent practice (corporates funnelling clients from online consults to their practices).
Other drawbacks identified by respondents were:
Amongst the written drawbacks, the biggest themes concerned abuse of drugs and antimicrobial resistance.
When those who had selected a drawback were then asked which was the biggest, 83.3% said ‘Harm to animals caused by misdiagnoses and missed diagnoses”
So in simple terms, in weighing up the pros and cons, it’s between the reduced cost to the owner on the one hand, cited by 70.9%, and harm to animal welfare on the other, cited by 94%. And the harm to animal welfare was selected by significantly more vets as the biggest concern, than reduced cost was selected as the biggest benefit.
In other words, vets think remote prescribing will make veterinary care cheaper, but at the overall cost to animal welfare.
British Veterinary Association President Malcolm Morley said: “New technology presents many opportunities to enhance existing veterinary services, with potential benefits for vets, clients and patients.
"However, we recognise there are concerns within the profession, particularly around the potential unintended consequences of the RCVS’s revised guidance on ‘under care’ in relation to animal welfare and access to veterinary services.
"This survey echoes these concerns as well as supporting the British Veterinary Association’s call for the RCVS to commit to a post-implementation review.”
The Disciplinary Committee has suspended a veterinary surgeon from the register for three months, for not carrying out or arranging the euthanasia of a cat, and for dishonesty in his subsequent account of events.
At the outset of the two-day hearing, Mr Bogdanowicz admitted all the parts of the charge, which related to events occurring around 24 June 2011, whilst he was working at Best Friends Veterinary Group, Thrapston.
The Committee was asked to decide if Mr Bogdanowicz's actions amounted to serious professional misconduct and to decide upon any sanction.
Mr Bogdanowicz had been requested by the owners of Jason, a 14-year old Maine Coon cat, to undertake euthanasia, rather than further treatment following abdominal surgery.
Unknown to Jason's owners, Mr Bogdanowicz instead allowed a registered veterinary nurse to take the cat home, from where it subsequently escaped.
Mr Bogdanowicz then colluded in an attempt made by the veterinary nurse to cover up what had occurred and only told the truth when discrepancies in the nurse's story were challenged by the practice.
In mitigation, the Committee was satisfied Mr Bogdanowicz's decision not to put the cat to sleep was taken without full reflection on the consequences of the decision.
It was also satisfied that there was no evidence of injury to Jason and no payment had been sought or made for putting the cat to sleep. He had apologised to the cat's owners and was truthful to the College after the complaint was made.
Mr Bogdanowicz had an otherwise unblemished career and produced impressive testimonials from his clients as evidence of the high regard in which he was held.
However, the Committee also found that despite having had several occasions to tell his employers the truth, Mr Bogdanowicz had done so only after inconsistencies were revealed in the account of the veterinary nurse.
By not asking for the cat to be brought back for a post-operative check, Mr Bogdanovicz had also abdicated his own professional responsibilities.
Judith Webb, chairing and speaking on behalf of the Committee said: "The Committee considers that it is unlikely that Mr Bogdanowicz will put himself in a similar position again. Having heard his evidence, it has formed the view that he has learnt his lesson from these proceedings.
"The Committee considers that it would perform a disservice to the community at large to direct a lengthy suspension of Mr Bogdanowicz's name from the Register."
The Committee directed that Mr Bogdanowicz's name be suspended from the Register for three months.
Leucogen is the world’s first recombinant subunit vaccine containing purified p45 FeLV-envelope antigen. Leucofeligen is a fully authorised combination vaccine for FeLV, rhinotracheitis, calicivirus and the feline panleucopaenia virus.
Virbac says that once into the 3 year immunity period for FeLV, cats may be given annual boosters against feline rhinotracheitis calicivirus and panleucopenia in the intervening years with Feligen RCP.
Tara Smith, Product Manager at Virbac UK, said: "This is a great development for Leucogen and Leucofeligen. We’re really excited to show practices the practical benefits that this extended duration of immunity offers, from improving the profitability of pet health plans to adapting the vaccine programme to suit the cat’s needs".
For more information, contact your Virbac Territory Manager.
After the contamination was first identified, sales of the product in Australia were stopped immediately and Bova initiated an investigation.
The British Horseracing Authority then conducted its own analysis of samples of the UK product, discovering that it too was contaminated with testosterone.
However, Bova says the levels of testosterone in the end product were confirmed to be 400-700 pg/ml, which is less than one millionth of the internationally accepted standard for impurities (1 picogram being equal to one billionth of a milligram).
Nick Bova, managing Director of Bova UK, said: "We have consulted veterinary pharmacologists and sports medicine specialists who have given their opinion that these levels are within accepted standards and could neither have a clinical effect nor result in a positive blood or urine test for testosterone in competition horses.
"The levels of testosterone within the product are inconsequential compared to endogenous production in mares and geldings as well as stallions and higher levels are found frequently in feed and water sources; testosterone being a common compound produced by humans and animals from multiple organs."
The source of the contamination was traced to the excipient used in the product, which was used by Bova Aus and Bova UK. Both companies have now switched their supplier of this excipient. Bova says all testing done on the new supplier has shown no traces of testosterone, even with the new extra sensitive method of analysis which is capable of reaching picogram levels.
Nick added: "Whilst we hope to reassure you that the use of long acting injectable omeprazole will not have had adverse implications for your patients or clients we can also reassure you that we are not complacent about the presence of impurities in any of our products, particularly an impurity that is of such significance to equestrian sport.
"Although the level of impurities is well within the accepted international standard, we have changed the supplier of the excipient in question. We have established an analytical method capable of testing down to picogram levels, which has been used to test the end product to ensure there are no further concerns with future batches.
"We sincerely apologise for any inconvenience this issue may have caused. Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment and we can reassure anyone who has used the product in recent months, or has product that they are due to use, that they can do so safely.
"However, we would draw attention to the recent statement from the BHA that they do not wish the product to be used in horses in training currently."
Visit www.bova.co.uk for further information.
251 veterinary surgeons and 124 veterinary nurses took part in the Permanent Salary Survey. 109 veterinary surgeons and 51 veterinary nurses took part in the Locum Pay Rate Survey.
The majority of respondents to the Permanent Salary Survey (69%) worked in the Midlands and south, but the survey didn't make any allowance for experience or qualifications, so it's difficult to read much into the reported figures. However, they were as follows:
Veterinary Surgeons
Veterinary Nurses
Under £15K
n/a
12.98%
£16K to £20K
<£20K 5.84%
40.46%
£21K to £25K
8.03%
38.93%
£26K-£30K
12.04%
6.87%
£31K-£35K
20.80%
>£30K 0.76%
£36K-£40K
24.09%
£41K-£45K
13.14%
The Locum Pay Rate Survey also made no allowance for experience or qualifications, but it may be that locum pay rates are less experience-sensitive than permanent salaries.
<£180
9.84%
<£8
0%
£180-£190
1.64%
£8-£9
1.72%
£190-£200
2.46%
£9-£10
£200-£210
5.74%
£10-£11
3.45%
£210-£220
6.56%
£11-£12
5.17%
£220-£230
17.21%
£12-£13
17.24%
£230-£240
13.11%
£13-£14
13.79%
The average charge rate for locum veterinary surgeons was £210 per day, and for veterinary nurses, around £13.50 per hour. The majority of the locum respondents (69%) worked in the Midlands and south.
Interestingly, 53.5% of the locums polled said that demand for their services had increased over the year.
If you are a locum, don't forget to complete your profile on VetSurgeon.org and add your flag to the VetSurgeon Locum Map.
Mr Eccles had first appeared before the Disciplinary Committee in November 2018 where he admitted a number of clinical failings regarding his diagnosis of a cat, the keeping of accurate and detailed clinical records, giving the animal appropriate treatment, surgery and care, and failing to provide the cat’s owners with adequate information on the cat’s care upon discharge.
After Mr Eccles admitted the two charges against him, and the Committee found him guilty of serious professional misconduct, the Committee then postponed its decision on sanction on the condition that Mr Eccles agreed to abide by a set of undertakings in the interim. They included: the preparation of a personal development plan, the enrolment of his practice in the RCVS Practice Standards Scheme, the appointment of a veterinary mentor, the completion of additional training and CPD, and his agreement to pay any costs of complying with the undertakings, including the appointment of and work undertaken by the appointed mentor.
At the resumed hearing last week, the Committee received evidence from Mr Eccles confirming that he had complied with all the original undertakings agreed to in 2018. It also considered some further undertakings that Mr Eccles had agreed to in October 2020 when his reconvened hearing was postponed due to the coronavirus pandemic. They included: confirming his compliance with the personal development plan he had drawn up in 2019, his practice achieving the Core Standards accreditation level within the Practice Standards Scheme, continuing to meet with his veterinary mentor, and undertaking additional CPD – all of which were found to be completed.
The Committee also heard evidence from both the veterinary mentor and Mr Eccles himself. In his evidence, Mr Eccles apologised to the owners of the cat for the care he had provided, admitting that he had let them and himself down by not having sufficient knowledge to recognise the cat’s needs and to provide him with a sufficient level of care. He also confirmed he was continuing to make improvements to his practice and that he had enjoyed the process of being mentored.
Dr Martin Whiting, chairing the Committee and speaking on its behalf, said: “In November 2018, Mr Eccles practice had fallen significantly short of an acceptable and adequate standard. He was a sole practitioner who had drifted away from professional standards.”
“The Committee today considers that Mr Eccles has met the undertakings which he accepted in November 2018 and again in October 2020 when the resumed hearing was adjourned owing to Covid-19. It accepts the College’s analysis as to how those standards have been met. It notes that Mr Eccles’ practice has achieved accreditation in Core Standards under the Practice Standard Scheme, something which is voluntary in ordinary practice. That is an exacting scheme. He has engaged with his mentor and had indicated that he will continue to do so as the need arises in order to maintain his development.”
Dr Whiting added: “The Committee also recognises that this was a single incident in a long career. It accepts that he has shown insight into his shortcomings. He understands what went wrong and why. The Committee was impressed with Mr Eccles’ statement of apology in his oral evidence today.”
“The Committee found the language which he used in answering its questions, as to the effect compliance with the undertakings has had upon him professionally, reassuring. He said he had been rejuvenated and stimulated; he had renewed enthusiasm for the profession. The Committee commends him for exceeding the minimum requirement of the undertakings, despite the stressful context of the Covid-19 pandemic.”
In considering its sanction for the original admitted charges from November 2018, the Committee considered that a reprimand and warning as to future conduct was the most appropriate and proportionate sanction.
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
Mr Doherty was convicted, with others (who were also convicted), in a conspiracy to deceive members of the public by passing off puppies that had been bred in puppy farms as being the home-bred offspring of domestic pets living in family homes.
Mr Doherty’s role was that he provided vaccinations and vaccination/health check cards which, the court found, materially contributed to the impression that the puppies had been home-bred locally and were in good health.
Mr Doherty was initially convicted of this offence, resulting in eight months’ imprisonment in April 2018.
However, he subsequently appealed the conviction, which was quashed and resulted in a retrial.
On retrial, Mr Doherty was convicted and sentenced to 24 months’ imprisonment, suspended for 18 months, 150 hours community service and a £100 victim surcharge.
When deciding on the sanction, the Disciplinary Committee considered that a period of suspension would be sufficient to meet the public interest.
In reaching this conclusion, the Committee took into account that Mr Doherty had, as part of his original conviction, already served eight months in prison before the original conviction was quashed and replaced, on retrial, with a suspended sentence.
He had therefore already, in effect, had a period of suspension from practice, which meant that the deterrent factor in a sanction of suspension had been partially met.
In reaching its decision, the Committee also took into account the circumstances of this case and, in particular, the view of the court that Mr Doherty had been motivated solely by animal welfare concerns and not financial gain, and that it was this overriding concern that had allowed others to exploit his willingness to continue to vaccinate puppies despite their source.
There were no concerns as to Mr Doherty’s skill or dedication as a veterinary surgeon and with regard to the single issue of the appropriate vaccination of puppies and their onward sale, the Committee noted the changes that Mr Doherty had made to his practice procedures to avoid any similar problems occurring in the future.
The full decision and findings from the hearing can be found at www.rcvs.org.uk/disciplinary
The range includes a water additive which received a Veterinary Oral Health Council (VOHC) approval after being shown to deliver a reduction in calculus of at least 20% in two studies¹.
The other products in the range are a gum spray and a malt flavoured toothpaste.
Animalcare says each has been designed to support owner compliance through ease of use and accompanying educational materials.
The company has also launched a website for veterinary professionals and pet owners: https://dental.pet.
For owners, the site has information on the importance of dental health in pets and advice on establishing a dental care regime.
For veterinary professionals, resources include 'talk tracks' to start discussions with clients about dental care and tools to help them recognise signs of dental pain.
Animalcare Product Manager Eleanor Workman Wright said: “Despite research showing that at least 80% of dogs and 70% of cats are likely to develop periodontal disease by the age of three², dental care is still often neglected.
"While tooth-brushing is cited as the gold standard, it has to be used daily to achieve a significant degree of efficacy.
"This is often just not possible in the ‘real world’ and a more flexible approach can be helpful, with products such as water additives and gum sprays offering a practical, less time-consuming solution in some circumstances."
“Products should be grounded in science which is why we are delighted that the Plaqtiv+ Water Additive has just become the first European product of its type to earn approval from the VOHC.”
References
A three and a half year old white German shepherd dog from Dorchester, Dorset, has become the first in the world to have an ankle amputation prosthesis.
Mitzi Davis was trampled by a horse which crushed her foot, tearing off all blood and nerve supply, back in October 2010.
In a pioneering procedure, Dr. Noel Fitzpatrick from Fitzpatrick Referrals fitted a titanium implant to the bone below her joint - the first time a prosthesis has been put in a fully articulating bone of a dog.
The ITAP implant (which stands for Intraosseous Transcutaneous Amputation Prosthesis) is a new way of attaching prosthetic limbs. It involves implanting a titanium rod in the bone, onto which skin can attach just like a deer's antler, leaving a "peg" sticking out of the skin which can't get infected because of the resilient seal. The technology was developed for dogs by Professor Gordon Blunn at University College London (UCL) in association with Dr. Fitzpatrick.
The "exo-prosthesis" or foot is then screwed onto the peg and can be changed and modified as necessary. First Mitzi's gait had to be modelled on a computer, much like in a CGI movie. Then a foot was made using computer finite element analysis, designed so that the material of the foot would absorb shock from the ground and, most importantly, snap and break before the implant in the bone or the bone itself.
Dr. Noel Fitzpatrick said: "Today of course has implications not only for animals but for human amputees in the future and I will continue to work closely with Professor Blunn and the Stanmore Implants team to advance this technology to improve the quality of life for animals and eventually, for humans."
The ITAP technology is being tested in humans and has already been used to create a prosthetic for a woman who lost her arm in the July 2005 London bombings.
Professor Blunn said: "Humans and other animals share a large number of degenerative musculo-skeletal conditions. The repair process of the musculoskeletal system is essentially the same whether in a dog, cat or human being. Reconstruction of the musculoskeletal system share common problems and the interchange of information between both veterinary and human orthopaedics is very important. Therefore treating animals is not only ethical in its own right but is a useful paradigm for human orthopaedics.
"Treating Mitzi with an ITAP device has proved to be beneficial and the information learned from this case has been directly applied to human surgery. Mitzi's ITAP is made from titanium alloy which is attached to the residual bone. The surface of the implant is coated with hydroxyapatite which enhances bone attachment, securing the implant in place. Part of the implant just underlying the skin has a surface which encourages dermal and epidermal attachment. This ties the skin into the implant and produces a seal preventing infection. This implant has been adopted for human use."
Dr Linda Prescott-Clements, RCVS Director of Education, said: “The overall aim of this event is to gather stakeholders' thoughts and insights on the need for GP specialty training, the potential impact and advantages to the profession as well as any potential risks.
"Those in attendance will also discuss what appropriate content for this training should be and explore potential learning environments, and prerequisites for how the training might be implemented”.
“After an introduction to the VCCP project, we will then be asking participants to consider some of the key questions around the development of this curriculum.
"This includes: establishing the overarching purpose of the training programme with reference to the needs of the workforce, the profession and veterinary care services; identifying appropriate areas of content for the training; identifying suitable learning environments; and establishing consideration of the required mechanisms of supervision and support.
“In terms of attendees, we are very keen to have a good mix of people including those working in independent veterinary practices as well as corporate environments, those working in general practice, Advanced Practitioners, Specialists and those who work in the education sector.
"The focus groups will be on interactivity, finding solutions and building engagement – we want all voices to be heard and all ideas to be shared.”
https://www.eventbrite.co.uk/e/rcvs-veterinary-clinical-career-pathways-stakeholder-focus-group-tickets-873231397617?aff=ebdssbdestsearch
COMMENT
Given the above-inflation rise in the cost of veterinary care, leading to the Competition and Markets Review and the proposed Formal Market Investigation, is now really the moment to be adding yet another layer of training and qualification, with attendant costs which will ultimately be borne by the pet-owning public?
And where is the need for a Specialist status for general practitioners?
Isn't one of the biggest issues facing general practitioners today the referall (sic) culture which has developed in recent years, leading to the deskilling of GPs, reduced job satisfaction and increased costs for pet owners?
Isn't it now the time to call a halt to further specialisation and instead focus on cutting costs, reducing the regulatory burden, and encouraging all GPs to regain lost skills so they can all deliver first class, affordable, pragmatic care for the masses?
Just a thought.
The charity says that although histiocytic sarcoma is rare, it is an aggressive form of cancer which Flatcoated Retrievers are particularly susceptible to.
According to the AHT, almost half of all affected Flat-coated Retrievers will have a tumour in multiple locations in the body at the time of diagnosis. The outlook for these dogs is very poor and, in most cases, means they receive a terminal diagnosis.
The new research revolves around microRNAs, abnormal levels of which are often found in tumours. In addition, different microRNAs are involved in different cancers. These cancer-specific microRNA signatures can be found within the blood of cancer patients, meaning that a tumour could potentially be diagnosed with a blood test.
To start with, the researchers say they plan to confirm if there is a specific microRNA signature that is unique to histiocytic sarcomas amongst tumours and normal tissue samples from Flatcoated Retrievers. If a signature is identified, the project will investigate if measuring the levels of these microRNAs within a Flatcoated Retriever tissue sample can be used to accurately identify a histiocytic sarcoma. If it can, additional funding will be sought for more research to identify if the microRNA signature is also detectable in the blood of affected dogs, and thence to develop a blood test.
If it comes off, this would mean that a blood sample from a Flatcoated Retriever that was lame, or was showing non-specific clinical signs of the disease such as depression, lethargy, appetite or weight loss, could be tested for the presence of the histiocytic sarcoma-associated microRNAs.
A dog with a positive test result could then have an early MRI scan and histopathology done to confirm the diagnosis, hopefully at a stage where treatment would be more successful.
Dr Anna Hollis, cancer researcher at the Animal Health Trust, said: "I have Flatcoated Retrievers and have lost one of them to histiocytic sarcoma - it is absolutely devastating. This research could make a significant difference, and that is a huge personal motivation for me. Histiocytic sarcoma is a particularly tricky cancer to diagnose, because the tumours are frequently located deep within or between the muscles of the upper limbs - underneath the shoulder is a common location.
"Often lame dogs are rested and given pain relief before imaging is sought. Delayed diagnosis is a potential problem with histiocytic sarcoma given its aggressive nature and ability to spread rapidly to other locations within the body. If we could identify affected dogs at an earlier stage, this may allow more successful treatment of the disease."
The research project has been funded by the Flatcoated Retriever Society (FCRS) and the FCRS Rescue, Rehousing and Welfare Scheme. The Flatcoated Retriever Breed Health Co-ordinator, Liz Branscombe, said "Sadly, there is a high incidence of this aggressive form of cancer in our beautiful breed. Early detection of the disease is key in optimising cancer treatment and prolonging survival time so the prospect of a diagnostic blood test for use in the future is exciting.'
Photo: Liz Branscombe, Dr Mike Starkey and Dr Anna Hollis of AHT and Brian Jones of FCRS Rescue, Rehousing and Welfare.
Under Schedule 3, vets can delegate medical treatment and minor surgery (not involving entry into a body cavity) to registered veterinary nurses and student veterinary nurses under certain circumstances.
However, following an RCVS survey of the profession to gauge how well both vets and vet nurses understood the provisions of Schedule 3, the College says it was clear that both groups, but especially vets, could benefit from additional guidance and greater clarity.
Following the publication of the survey report, the RCVS Veterinary Nursing Schedule 3 Working Party made a number of recommendations, including the production of a number of case studies (available via www.rcvs.org.uk/schedule3) and a reference poster to help veterinary surgeons in making decisions on delegation in practice.
An A3/A4 poster setting out the principles of delegation has now been prepared and will be printed and posted to all UK veterinary practice premises this autumn.
Ian Holloway, RCVS Director of Communications, who helped develop the poster with the RCVS Standards Committee and the College’s Standards & Advice Team, said: "It was clear from the survey results that we could do more to help vets and vet nurses understand and remember the principles of delegation under Schedule 3, so hopefully our six-point checklist, using the memorable mnemonic 'SUPERB', will do just that.
"If the poster can be placed in a prominent position in the practice setting, we hope it will become a handy, everyday reference tool for all veterinary professionals, and help vets remember the six questions they need to consider before delegating work to their VN colleagues.
SUPERB stands for:
Specific procedure – is the procedure medical treatment or minor surgery not involving entry into a body cavity?
Under care – is the animal under your care?
Person – can you delegate to this person?
Experience – does the RVN/SVN feel capable, and have sufficient competence and expertise?
Risks – have you considered the risks specific to this case?
Be there – are you available to direct or supervise as necessary?
Only if you, as a vet, can answer 'yes' to all six questions, can you delegate the job to an RVN or SVN.
The poster will also available to download from www.rcvs.org.uk/schedule3 where further resources about delegation are available, including links to the relevant chapter of the supporting guidance to the RCVS Code of Professional Conduct and the Schedule 3 case studies.
I think anything which gives veterinary surgeons confidence to delegate more is to be warmly welcomed. But what do you think? Will this poster encourage you to delegate more, or less, or the same? Discuss here.
According to the company, canine dry eye affects 1 out of 22 dogs and the early symptoms can be easily missed by pet owners, leading to irreversible damage to a dog’s vision, and eventually resulting in blindness.
If you want to get behind the campaign, MSD will supply your practice with a educational video and a special pair of glasses which mimic the effect of dry eye on a dog, so you can better explain the condition to clients and encourage them to book a screening appointment / Schirmer tear test if their pet is at risk.
Middle-aged to older dogs and certain breeds such as Cavalier King Charles Spaniel, West Highland White Terrier, Shih Tzu, Cocker Spaniel, Pekingese, Yorkshire Terrier, Lhasa Apso, Pug and Bulldog are more prone to KCS. Dogs with sore eyes and/or affected by conditions such as diabetes, Cushing’s Disease and hypothyroidism may also develop canine dry eye and MSD says they should be tested.
Caroline Darouj, product manager at MSD Animal Health, said: "Certain breeds of dog suffering from pre-existing conditions are at higher risk for canine dry eye and vets should screen regularly for canine dry eye."
“If left untreated, canine Dry Eye can lead to blindness. However, if caught in time, it can be well managed with medication.”
For more information, visit www.optimmune.co.uk
MDC Exports has launched a new Soft E Collar specifically designed to help greyhounds recover, post-op.
MDC says the new Soft E Collar has been designed to take into account a greyhound's long fragile neck and to make wearing a medical collar much more comfortable. It also features a drawstring design to prevent the animal from being able to back out of the collar, something the company says is a particular problem when greyhounds wear conventional collars.
According to MDC, the Soft E Collar acts as an effective barrier to a treatment area while ensuring an animal can eat, drink and sleep comfortably. It allows free movement of the head, neck and body so the animal can carry on as normal. And unlike traditional "Elizabethan" collars, the Soft E Collar is made out of soft fabric that is non-allergenic, non-toxic and water repellent. It is tough and easily able to withstand persistent clawing and chewing. Lastly, it is lightweight and very flexible, folding flat for ease of storage and springing back to its original shape when you are ready to use it.
The Soft E Collar for greyhounds is priced from £7.95. For more information visit http://www.mdcexports.co.uk/
This is by no means Mars's first foray into practice ownership. The company has been acquiring practices in the USA since 1994 and now owns VCA, Banfield Pet Hospital, Bluepearl and Pet Partners, through which it employs around 50,000 veterinary professionals and cares for approximately 10 million animals.
Alejandro Bernal, Vice President, Veterinary Health Group, Mars Petcare said: "Pet care has been an important part of Mars for over 80 years and Mars has a large and growing veterinary practice in the US. This strategic acquisition reaffirms our commitment both to the pet care industry and veterinary profession.
"Alongside our other veterinary businesses, Linnaeus will enable Mars Petcare to provide pets with even greater access to high-quality veterinary care. Its reputation as a leading partnership of highly-respected veterinary practices and professionals means that it is well placed to meet the increasing demand in the UK and help drive our purpose, to create a better world for pets."
Lynne Hill, Chief Executive Officer of Linnaeus and former RCVS President said: "Joining Mars Petcare will enable us to provide pets with even greater high-quality veterinary care, from wellness and prevention, through primary, emergency and specialty care."
Mars says that on completion of the deal, Linnaeus’s existing management will continue to lead the business.
Encouragingly, 88% of the 5046 people surveyed said they keep guinea pigs in groups of two or more, as is recommended by experts and, in fact, required by law in Switzerland. 88% also said they provide their guinea pig with additional space to roam outside of their housing.
Although only 3% of guinea pig owners said they insure their pet, 67% said they take their guinea pig to see the vet once a year or more.
When it comes to nutrition, 76% of owners say they believe feeding hay is the most important part of their guinea pig(s) diet and 65% say it is their guinea pigs’ primary food source. Burgess says that in an ideal world 100% of guinea pigs would be fed hay as their primary food source, so 65% shows there is room for improvement.
Peter Lancaster, marketing manager at Burgess Pet Care said: "Guinea pigs make fantastic pets but, as with other small animals, they have very particular needs when it comes to their welfare. Thankfully, according to the findings of our census, we found that the majority of guinea pig owners who provided answers on the five welfare needs – diet, company, health, environment and behaviour, are conscientious with their care, reflecting their dedication to keeping their pets happy.
"It was fantastic to see the number of guinea pig owners entering the census keep rising by the day, and we’re reassured that there are thousands of well-informed owners out there. However, despite these resoundingly positive findings, there is always work to be done when it comes to improving standards of animal welfare. The information we’ve received from this census does identify the gaps of knowledge in certain areas, and we anticipate these gaps to be much larger when it comes to less-informed and engaged guinea pig owners."
CardioCare is based on research carried out at the Purina Technology Center which explored how nutrients can support the ailing heart. First, a series of metabolomics studies identified metabolic changes that occur in MMVD. Then the company developed a ‘Cardiac Nutritional Blend’ to address these metabolic changes and evaluated it in a clinical study.
The main elements of the Cardiac Nutritional Blend include carnitine precursors, antioxidants and medium-chain triglycerides. Purina says the latter provides an alternative energy source that is easy for the struggling heart to use, something which is particularly important as the metabolomics research revealed that dogs with MMVD showed less efficient cardiac energy metabolism1.
The company highlights a 2019 clinical study, which showed that the Cardiac Nutritional Blend has the potential to delay disease progression in dogs with preclinical MMVD. Over the six-month study period, dogs with preclinical MMVD fed the Cardiac Nutritional Blend showed a reduction in left atrial size, while an equivalent group of dogs fed a control diet showed an increase. Additionally, none of the dogs fed the Cardiac Nutritional Blend progressed from stage B1 to B2 during the study, while 37% of dogs fed the control diet showed progression2.
Purina also says that while the research to date has focused on MMVD, the nutrients in CardioCare are recognised to be beneficial under conditions of cardiac stress and the diet may prove a useful tool to provide support in a wider range of conditions. The company recommends that the diet be considered as part of the management plan for any dog with cardiac insufficiency.
Dr Libby Sheridan, Purina Scientific Affairs Manager for the UK & Ireland, said: "Metabolomics research has the scope to drive huge advances in managing a range of conditions. We’re proud to be at the forefront of this exciting field and bring the benefits of our findings to vets in practice.
"CardioCare opens up a new avenue of support for patients with cardiac insufficiency and vets can use this diet as a tool to complement medical treatment."
CardioCare will be available from 30th June. Contact vettechline@purina.nestle.com for more information.
Locum David John Porter has been struck off by the RCVS Disciplinary Committee for rude and aggressive behaviour, deficient clinical standards and obstructing the Committee's investigation into the complaints against him.
Three charges were found against Mr Porter.
The first charge (charge A) concerned failure to communicate courteously and respectfully with colleagues. This charge related to four incidents as follows:
In finding him guilty of this charge the Committee referred to his “wholly unacceptable exchanges with other veterinary surgeons and veterinary nurses and ancillary practice staff members with whom he was working on the dates in question.”
The second charge for which he was found guilty (charge C) concerned what the Committee called “his seriously deficient clinical standards when treating animals under his care”, in particular that:
Within charge C he was cleared of two further parts of the charge – first, that he failed to discuss euthanasia with a client in relation to a kitten and failed to provide the client with sufficient advice and instructions regarding after-care; and, second, that he prescribed steroids to treat a kitten for muscle strain at a time when it was recovering from surgery.
The third charge for which he was found guilty (charge D) relates to Mr Porter’s failure, between 7 February 2013 and 31 October 2014, to respond adequately to communications from the RCVS. In particular that:
As to the conduct found proved in relation to charge D, the Committee set out its findings of fact and declared: “What Mr Porter chose to do was to attempt to obstruct the College in its attempts to investigate the complaints laid against him and, thereafter, its attempts to bring him before the Committee to answer the charges preferred against him. In short, he has directly questioned, and then disregarded and thwarted, the legitimate role of his professional regulatory body.”
The Committee’s reasons for taking a serious view of such conduct were expressed in the following words: “Both the public and other members of the profession must be entitled to rely on the expectation that all veterinary surgeons, as responsible professional persons, will co-operate fully and promptly to all proper enquiries made of them by the College. This is the wider public interest factor which means that deliberate attempts to thwart the College’s enquiries into complaints must, in our judgment, come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect.”
During the course of the hearing, which began in June 2015 and was adjourned three times, Mr Porter was cleared of charge B against him which concerned alleged refusal to undertake out-of-hours work for the Clent Hills Veterinary Group having previously indicated he would undertake such work.
In making the decision on the sanction in this case, Judith Webb, chairing the Disciplinary Committee and speaking on its behalf, said: “In reaching our conclusion as to the sanction which is merited in this case we have taken into account the totality of Mr Porter’s conduct and failings. We consider that the conduct pertaining to Charges D(i) and (ii), even when viewed separately, demand the imposition of a direction for the removal of Mr Porter’s name from the Register.
“When that conduct is considered in conjunction with the other misconduct found proved in relation to Charges C1 to C4, which identify his clinical failings, and Charges A1 to A4, which demonstrate unprofessional behaviour in the workplace, we unhesitatingly conclude that there is no other sanction that could be considered sufficient, other than that of erasure.”
The company makes personalised, calorie-controlled fresh meals for dogs; 20 million of them since it launched in 2016.
Each recipe is made of human-grade ingredients and contains 60% single-source protein and 40% vegetables and lentils, with added minerals. There are no preservatives, derivatives or byproducts. Recipes such as "Chow Down Chicken," "Gobble Gobble Turkey," and "Swish Fish Dish" contain less than 5% fat content.
The meals are portioned specifically to each dog according to their calorific need. They are then delivered directly to the customer's door (free-of-charge) via a subscription model.
The model has proven so successful that Butternut Box has recently secured £20m in venture capital to grow the business.
The company launched a referral programme in early May, in which over 50 veterinary surgeons and nurses have signed up to become Butternut Box 'ambassadors'.
Each ambassador is give a unique discount web address which they can give to any client that would benefit from a freshly cooked, calorie-controlled diet for their dog.
If the client redeems the code, a one-time referral fee is credited to the ambassador's account, which can be transferred to a personal account, donated to charity or spent on Butternut Box food for their own use.
Kyle Kennedy from Butternut Box said: "We take great pride in the quality of our food. We think dogs deserve better, and we want to give pet professionals a food they can be proud to recommend."
For more information about being a Butternut Box ambassador, email: kyle@butternutbox.com.